United Imaging Healthcare

SHANGHAI – – October 29, 2026 -- United Imaging Healthcare (688271.SH) reported revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as overseas sales climbed 50.30% to RMB 3.00 billion.

R&D spending reaches 21.08% of revenue

The company invested RMB 2.23 billion in R&D over the nine months, equal to 21.08% of revenue and 0.14 percentage points higher than a year earlier. It employs 3,937 R&D staff. Cumulative R&D investment from 2022, the year of its public listing, through September 2026 totals RMB 10.50 billion.

Asia-Pacific revenue more than doubles, Europe grows nearly 30%

European revenue rose nearly 30% year-on-year in the period. Asia-Pacific revenue grew by more than 100% in Q1–Q3 2026, with progress in Singapore, Japan, South Korea, Australia and New Zealand.

SHANGHAI – October 29, 2026 -- United Imaging Healthcare (688271.SH) posted revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as international sales grew 50.30%.

Third-quarter revenue reached RMB 3.53 billion. Net profit attributable to shareholders rose 13% year-on-year to RMB 138 million.

International sales reach 28.31% of group revenue

Overseas revenue totaled RMB 3.00 billion in the period. Its share of total revenue rose 5.82 percentage points from a year earlier to 28.31%.

Europe revenue grows nearly 30% on 850-plus deliveries

Cumulative deliveries in Europe exceeded 850 systems, with high-end imaging equipment deployed in more than half of EU member states. A regional team of more than 160 employees supports the business. In North America, the company expanded relationships with integrated delivery networks and secured eligibility under framework agreements.